{"id":7632,"date":"2026-09-08T09:54:47","date_gmt":"2026-09-08T02:54:47","guid":{"rendered":"https:\/\/productregistrationindonesia.com\/"},"modified":"2026-09-08T09:54:48","modified_gmt":"2026-09-08T02:54:48","slug":"pregnancy-supplement-registration-indonesia","status":"publish","type":"post","link":"https:\/\/productregistrationindonesia.com\/id\/pregnancy-supplement-registration-indonesia\/","title":{"rendered":"Pregnancy Supplement Registration in Indonesia: How BPOM Assesses Your File"},"content":{"rendered":"<p class=\"wp-block-paragraph\">Most pregnancy supplement files that stall in Indonesia do not fail on safety. They fail on classification and on claim wording: two things decided long before the dossier is uploaded, and two things that are entirely within your control at the formulation stage.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">That is the practical shape of BPOM registration for this category. A prenatal or lactation-support product sits at the boundary between a health supplement and a medicine, and the boundary is drawn by what the product contains and what the label promises, not by who the product is for. Get either wrong and the file is not slow; it is in the wrong queue.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">This guide sets out how <a href=\"https:\/\/www.pom.go.id\/\" target=\"_blank\" rel=\"noopener\">BPOM<\/a> classifies pregnancy and breastfeeding supplements, the framework of instruments that governs registration, the stages a file moves through, and where files in this category actually break down. It reflects the rules in force as of September 2026, including a significant 2025 change to stability testing and a registration reform now moving through consultation.<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Key takeaways<\/strong><br>A pregnancy supplement is classified in Indonesia by its ingredients and its claims, not by its target user. Vitamins, minerals and amino acids within permitted limits, carrying nutritional claims, fall under the health supplement regime; anything implying prevention or treatment of a diagnosed condition such as pre-eklamsia is treated as a medicinal claim. Claim wording is governed by a dedicated claims guideline separate from the core registration regulation. Since March 2025 a dedicated stability testing guideline has applied, aligned to the ASEAN standard and treating Indonesia as tropical Climatic Zone IVB. A broader revision of the health supplement registration regulation entered public consultation in November 2025 to align it with Indonesia\u2019s risk-based business licensing framework.<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<figure class=\"wp-block-embed is-type-wp-embed is-provider-product-registration-indonesia wp-block-embed-product-registration-indonesia\"><div class=\"wp-block-embed__wrapper\">\n<blockquote class=\"wp-embedded-content\" data-secret=\"v6ngXf98hf\"><a href=\"https:\/\/productregistrationindonesia.com\/id\/health-supplement-registration-indonesia\/\">The Complete Guide to Health Supplement Registration in Indonesia for Foreign Exporters<\/a><\/blockquote><iframe class=\"wp-embedded-content\" sandbox=\"allow-scripts\" security=\"restricted\" style=\"position: absolute; visibility: hidden;\" title=\"\u201cThe Complete Guide to Health Supplement Registration in Indonesia for Foreign Exporters\u201d \u2014 Product registration Indonesia\" src=\"https:\/\/productregistrationindonesia.com\/health-supplement-registration-indonesia\/embed\/#?secret=SLUHEvDzo7#?secret=v6ngXf98hf\" data-secret=\"v6ngXf98hf\" width=\"600\" height=\"338\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\"><\/iframe>\n<\/div><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>How Indonesia classifies a pregnancy supplement<\/strong><\/h2>\n\n\n\n<figure class=\"wp-block-image size-full\"><img fetchpriority=\"high\" decoding=\"async\" width=\"1000\" height=\"667\" src=\"https:\/\/productregistrationindonesia.com\/wp-content\/uploads\/2026\/09\/Pregnancy-Supplement-Indonesia-BPOM-Registration-Guide-2.webp\" alt=\"Pregnancy Supplement Indonesia BPOM Registration Guide 2\" class=\"wp-image-7634\" srcset=\"https:\/\/productregistrationindonesia.com\/wp-content\/uploads\/2026\/09\/Pregnancy-Supplement-Indonesia-BPOM-Registration-Guide-2.webp 1000w, https:\/\/productregistrationindonesia.com\/wp-content\/uploads\/2026\/09\/Pregnancy-Supplement-Indonesia-BPOM-Registration-Guide-2-300x200.webp 300w, https:\/\/productregistrationindonesia.com\/wp-content\/uploads\/2026\/09\/Pregnancy-Supplement-Indonesia-BPOM-Registration-Guide-2-768x512.webp 768w, https:\/\/productregistrationindonesia.com\/wp-content\/uploads\/2026\/09\/Pregnancy-Supplement-Indonesia-BPOM-Registration-Guide-2-18x12.webp 18w\" sizes=\"(max-width: 1000px) 100vw, 1000px\" \/><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">Indonesia classifies a pregnancy supplement as a health supplement when it is intended to complement nutritional intake, maintain or improve health function, and is built from vitamins, minerals, amino acids and other non-plant substances that may be combined with botanical ingredients. The target user is not part of the test.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">This matters more in prenatal and lactation categories than almost anywhere else, because the surrounding health conditions are serious and the temptation to write a stronger label is correspondingly high. A brand that positions a product against hypertensive disorders of pregnancy, or promises a specific increase in breast milk output, has not written a bolder supplement claim. It has written a medicinal claim, and it will be assessed against a standard of evidence supplements are not built to meet.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Three practical consequences follow. First, classification is decided by your own formulation and copy decisions, which means it is reviewable before you file. Second, a classification granted in another market does not transfer: a product marketed as a food supplement elsewhere may be a health supplement, a quasi-medicine, or a medicine here depending on its composition and claims. Third, once a file is in the wrong category, the fix is a reformulation or a rewrite, not an appeal.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>The regulatory framework governing pregnancy and breastfeeding supplements<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Registration in this category is not governed by a single instrument. It sits across a stack of them, and the most common cause of a surprise during evaluation is a brand that read one and assumed it covered the rest.<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th><strong>Instrument (by function)<\/strong><\/th><th><strong>What it governs in practice<\/strong><\/th><\/tr><\/thead><tbody><tr><td>The national health law<\/td><td>The statutory ceiling. Maternal nutrition policy and BPOM\u2019s supplement authority both derive from it, and its implementing government regulation supplies the operative definition of a health supplement.<\/td><\/tr><tr><td>The core registration regulation<\/td><td>Criteria for safety, benefit, quality and labelling, plus the procedural route to a marketing authorisation number. This is the instrument your dossier is assessed against.<\/td><\/tr><tr><td>Its 2024 amendment<\/td><td>Adjusted the maximum permitted selenium intake for pregnant and breastfeeding women upward in combination form, and corrected the descriptive wording used for zinc supplements without changing its substance.<\/td><\/tr><tr><td>The health supplement claims guideline<\/td><td>The dedicated instrument governing what a health supplement may claim, the substantiation each claim category requires, and where a claim crosses into medicinal territory. This is the one that decides pregnancy and lactation copy.<\/td><\/tr><tr><td>The supervision regulation<\/td><td>Post-authorisation oversight: labelling in market, advertising, and enforcement.<\/td><\/tr><tr><td>The stability testing guideline (in force since March 2025)<\/td><td>Study design, evaluation and the shelf-life statement on the label. Aligned to the ASEAN stability standard and treats Indonesia as tropical Climatic Zone IVB.<\/td><\/tr><tr><td>The raw material risk assessment regulation (2025)<\/td><td>Risk review of ingredients used in health supplements, natural medicines and quasi-medicines, directly relevant to botanical galactagogues in lactation formulas.<\/td><\/tr><tr><td>The national antenatal iron-folate standard<\/td><td>Sets the composition benchmark used in the government\u2019s own antenatal programme, a reference point assessors are familiar with when reviewing comparable commercial formulas.<\/td><\/tr><tr><td>Risk-based business licensing standards (2025)<\/td><td>The licensing architecture the registration regime is currently being aligned to, following the 2025 government regulation on risk-based licensing.<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\"><em>We deliberately do not publish the instrument numbers, effective dates and article-level cross-references here. That mapping is the working substance of a regulatory consultancy, and in this category the correct instrument is frequently not the obvious one: claim wording, to take the most common example, is decided by a guideline that most brands have never opened because they were reading the registration regulation instead.<\/em><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>What changed recently, and what is changing next<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Three developments between 2024 and 2026 matter for anyone filing a prenatal or lactation product now.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/www.pom.go.id\/siaran-pers\/bpom-ubah-batas-maksimum-suplemen-selenium-untuk-ibu-hamil\" target=\"_blank\" rel=\"noopener\">The 2024 amendment<\/a> raised the maximum permitted selenium intake for pregnant and breastfeeding women in combination form, and corrected zinc labelling wording. BPOM described the change as grounded in scientific review with expert input. Notably, the Ministry of Health\u2019s nutrition and maternal-child health directorate publicly welcomed it as relevant to multi-micronutrient supplementation for pregnant women, an indication of where policy attention sits, though the amendment itself did not create a distinct multi-micronutrient registration route.<\/li>\n\n\n\n<li>A dedicated stability testing guideline took effect in March 2025 and now governs how shelf life is established for health supplements. It aligns Indonesia with the ASEAN stability annex, treats the country as tropical Climatic Zone IVB, and permits testing either at an accredited laboratory or at an industry\u2019s own internal laboratory holding a good manufacturing practice certificate. For imported products, this is the single most common source of avoidable requeries: data generated for a temperate market does not answer a Zone IVB question.<\/li>\n\n\n\n<li>A revision of the core registration regulation entered public consultation in November 2025, alongside the parallel quasi-medicine regulation, to align both with Indonesia\u2019s risk-based business licensing framework. BPOM has framed the goal as a more transparent, more efficient, risk-tiered registration mechanism. A new government regulation on BPOM fees was also issued in 2026. Anything you read about fee levels or processing tiers that predates these should be treated as stale.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">For a brand planning a 2027 launch, the practical implication is that the procedural surface of registration is in motion while the substantive criteria (safety, quality, permitted limits, claim boundaries) are stable. Build the dossier against the substance; take the procedure as of the week you file.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>The BPOM registration pathway, stage by stage<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The sequence below is an orientation map. Because the outcome depends on classification, composition and claim wording, it is not a schedule, and we do not publish generic timelines for this category: a file that is correctly classified and a file that is not do not belong on the same clock.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Classify first.<\/strong> Confirm the product qualifies as a health supplement rather than drifting into medicine or quasi-medicine territory through its ingredient profile or its claims. Do this before the formula is locked.<\/li>\n\n\n\n<li><strong>Establish standing.<\/strong> Establish the corporate and facility prerequisites: the entity holding the authorisation, importer or manufacturer status, and the applicable good manufacturing practice evidence for the production site.<\/li>\n\n\n\n<li><strong>Build the technical dossier.<\/strong> Composition and specification, manufacturing process, finished-product quality data, packaging specification and stability data designed under the current guideline for tropical Zone IVB conditions.<\/li>\n\n\n\n<li><strong>Review claims separately.<\/strong> Test the label and marketing copy against the claims guideline before submission, not after. Pregnancy-specific and lactation-specific wording is scrutinised more closely than general wellness copy, and translation is where compliant copy most often becomes non-compliant.<\/li>\n\n\n\n<li><strong>Submit through the registration portal.<\/strong> Pre-assessment checks completeness before technical evaluation begins. An incomplete file consumes a cycle without generating any assessment feedback.<\/li>\n\n\n\n<li><strong>Respond to evaluator queries.<\/strong> Prepare to substantiate composition, dosing rationale and any claim that touches physiological outcome.<\/li>\n\n\n\n<li><strong>Plan the parallel tracks.<\/strong> Run halal certification in parallel rather than after approval, and plan post-market obligations (labelling in market, advertising review, and adverse event reporting) from the start.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Stability and safety testing must be designed and conducted at a facility that meets the eligibility conditions in the current guideline. We cover facility selection in more detail in our guide to <strong>Food Testing Laboratory requirements in Indonesia.<\/strong><\/p>\n\n\n\n<figure class=\"wp-block-embed is-type-wp-embed is-provider-product-registration-indonesia wp-block-embed-product-registration-indonesia\"><div class=\"wp-block-embed__wrapper\">\n<blockquote class=\"wp-embedded-content\" data-secret=\"NMNjTiFpWP\"><a href=\"https:\/\/productregistrationindonesia.com\/id\/food-testing-laboratory\/\">Food Testing Laboratory in Indonesia: What BPOM Checks Before Registration<\/a><\/blockquote><iframe class=\"wp-embedded-content\" sandbox=\"allow-scripts\" security=\"restricted\" style=\"position: absolute; visibility: hidden;\" title=\"\u201cFood Testing Laboratory in Indonesia: What BPOM Checks Before Registration\u201d \u2014 Product registration Indonesia\" src=\"https:\/\/productregistrationindonesia.com\/food-testing-laboratory\/embed\/#?secret=5BwhNoH1qM#?secret=NMNjTiFpWP\" data-secret=\"NMNjTiFpWP\" width=\"600\" height=\"338\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\"><\/iframe>\n<\/div><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Claims: where pregnancy and breastfeeding files actually fail<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Claim wording is the single highest-frequency failure point in this category, and it is governed by a dedicated claims guideline rather than by the registration regulation most brands read.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The operative distinction is between supporting a nutritional requirement and promising a physiological outcome. A product may address the increased nutritional needs of pregnancy or lactation. It may not promise that it will prevent a diagnosed condition, guarantee a measurable increase in breast milk volume, or treat a complication of pregnancy. The first is a supplement claim. The second is a medicinal claim wearing supplement packaging, and it is routinely rejected.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Two failure patterns account for most of what we see. The first is the guarantee construction: copy phrased as a certainty rather than as support. The second is literal translation: copy that is lawful in its market of origin, rendered word-for-word into Indonesian, and landing as an unauthorised medicinal claim because the Indonesian phrasing carries a stronger implication than the source did. Neither requires reformulation to fix. Both require catching before submission.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>The maternal health backdrop assessors work against<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Regulatory decisions in this category are not made in a vacuum. Four maternal health issues are active national priorities in Indonesia, and they shape how closely a pregnancy or lactation file is read.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Micronutrient intake gaps in pregnancy<\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">The most specific national picture still comes from analysis of Indonesia\u2019s 2014 Total Diet Study, published in a peer-reviewed nutrition journal, which examined intake among 606 pregnant women. It found severe deficiency of intake in 88.3 percent of women for folic acid, 46.9 percent for vitamin C and 34.5 percent for vitamin B12. The folic acid figure is the striking one, and it is consistent with why iron-folate supplementation sits at the centre of the national antenatal programme. Note that this measures dietary intake rather than blood status, and the data is now over a decade old; we cite it because nothing more specific has replaced it, not because it is current.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">For formulation, the practical reading is that pairing vitamin C with non-heme iron mirrors an absorption relationship already embedded in the national programme, which makes the combination straightforward to justify on composition grounds.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Exclusive breastfeeding coverage<\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Insufficient milk supply is among the most commonly cited reasons Indonesian mothers stop exclusive breastfeeding early, and it is the demand driver behind most lactation-support formulas. The national coverage figures vary by methodology and are worth stating plainly rather than smoothing over.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/www.badankebijakan.kemkes.go.id\/en\/daftar-frequently-asked-question-seputar-hasil-utama-ski-2023\/hasil-utama-ski-2023\/\" target=\"_blank\" rel=\"noopener\">The 2023 national health survey<\/a> put exclusive breastfeeding among infants aged 0 to 5 months at 68.6 percent nationally, and at 55.5 percent on its six-month composite measure. The national statistics agency\u2019s March 2025 household survey, cited by the population and family development agency, put the 0-to-5-month figure at 72.3 percent, and reported a gap by maternal employment: 68.57 percent among working mothers against 74.07 percent among mothers who do not work. The provincial spread in the 2023 survey was wide, from the high eighties down to the high forties.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The direction is consistent across sources, and it explains why lactation claims are read carefully. Wording that overstates what a supplement can do is landing on an anxiety that is already widespread.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Trace minerals and stunting<\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Zinc, iodine and selenium are the trace minerals we field the most formulation questions about, and they are frequently under-supplied in standard Indonesian prenatal diets in ways that connect to fetal neurodevelopment.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The clearest national proxy is stunting. The 2024 national nutrition status survey, released in mid-2025, recorded national stunting prevalence at 19.8 percent, down from 21.5 percent the year before, against an interim target of 18.8 percent for 2025. Provincial variation is wide, from 8.7 percent in Bali to 40 percent in Papua Pegunungan, with Nusa Tenggara Timur second at 37 percent. The survey was not repeated in 2025, so 19.8 percent remains the most current survey-based national figure.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Because stunting traces partly back to maternal nutritional status during pregnancy, trace mineral dosing is read against this backdrop rather than in isolation. Dosing at the top of the permitted range without proportionate supporting data attracts more questions than dosing in the middle of it; the ceiling is a limit, not a target.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Pre-eklamsia<\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">In April 2026, marking Hari Kartini, the <a href=\"https:\/\/kemkes.go.id\/eng\/peringati-hari-kartini-kemenkes-perkuat-deteksi-dini-preeklamsia-berbasis-teknologi\" target=\"_blank\" rel=\"noopener\">Ministry of Health launched a technology-based early detection programme for pre-eklamsia,<\/a> noting that the condition (which is believed to have killed Kartini herself over a century ago) remains Indonesia\u2019s second-largest direct cause of maternal death, contributing roughly a quarter of all cases. Indonesia\u2019s maternal mortality ratio sits at around 140 per 100,000 live births, with a stated five-year target of 40. Ultrasound units have been distributed to 10,000 puskesmas since 2022 to widen early screening access.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">None of this changes what a supplement may lawfully claim. A pregnancy supplement cannot claim to prevent or treat pre-eklamsia, regardless of how promising a nutrient\u2019s research profile appears. What it does change is the reading temperature: assessors are working against a backdrop in which this specific condition is a declared national priority, and borderline wording in that territory does not get the benefit of the doubt.<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Quick answer<\/strong><br>Indonesia\u2019s pregnancy supplement market is shaped by four measurable pressures: micronutrient intake gaps in pregnancy, incomplete exclusive breastfeeding coverage, trace mineral deficiency linked to stunting, and pre-eklamsia\u2019s continued role as the second-largest direct cause of maternal death. None of these permit a therapeutic claim. All of them raise the scrutiny applied to composition and claim wording in this category.<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>What this looks like in practice: three registration files<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><em>The following are composite, anonymised scenarios built from patterns we see repeatedly across pregnancy and breastfeeding supplement files. They are illustrative rather than case records.<\/em><\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Permissible selenium level<\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">A brand with an established prenatal multi-micronutrient formula had built its Indonesian composition to an older ceiling for selenium in pregnancy and lactation, on the assumption that the earlier limit still applied. The 2024 amendment had moved it. The practical consequence was not a rejection; it was an unnecessary reformulation and a lost quarter, undertaken to solve a constraint that no longer existed.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The lesson is unglamorous. Permitted limits in this category are revised, and they are revised specifically for pregnancy and lactation. Building to a limit you verified two years ago is a live risk in both directions.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>A zinc dose that needed better data<\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">A supplement formulated for a humid export market carried zinc near the upper end of the permitted range. The first submission came back with questions, not because the dose was impermissible, but because the stability data on file had been generated under conditions that did not reflect Indonesian storage climate.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Rather than lowering the dose and losing the formulation\u2019s point of difference, the brand commissioned fresh accelerated stability testing designed for tropical Zone IVB at an eligible facility. The dossier was resubmitted with that data and cleared without further queries on mineral content. Under the 2025 stability guideline this scenario is now more avoidable than it used to be, because the design expectations are set out explicitly.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>A lactation claim that needed rewording, not removal<\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">A breastfeeding supplement\u2019s draft label stated in Indonesian that the product increases breast milk production, phrased as a direct guarantee. That construction reads as a medicinal claim under the claims guideline and was flagged during pre-submission review.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The formulation did not change. The claim was rewritten to describe the product as supporting maternal nutritional needs during lactation rather than promising a physiological outcome. That single wording shift is the difference between a claim that would likely be rejected and one that sits comfortably inside the permitted framework.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Common mistakes when registering a pregnancy or breastfeeding supplement<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Most rejections and resubmissions we see in this category trace back to a small and repeatable set of errors. None are exotic. All are cheaper to prevent than to correct.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Assuming an imported product\u2019s classification carries over. A product classified as a food supplement elsewhere is not automatically a health supplement in Indonesia. Classification is decided under Indonesian rules against Indonesian definitions.<\/li>\n\n\n\n<li>Wording claims as therapeutic outcomes. Copy implying prevention of pre-eklamsia, a guaranteed increase in breast milk, or treatment of a diagnosed condition crosses into medicinal territory and is routinely rejected.<\/li>\n\n\n\n<li>Translating labels literally instead of adapting them. Compliant source copy regularly becomes non-compliant Indonesian copy, particularly around lactation and pregnancy wording.<\/li>\n\n\n\n<li>Reusing stability data from a temperate market. Indonesia is treated as tropical Zone IVB, and the current guideline sets out design expectations explicitly. Borrowed data is the most common avoidable requery on imported files.<\/li>\n\n\n\n<li>Dosing at the permitted ceiling without proportionate supporting data. Zinc, iodine, selenium and iron formulations pushed to the top of the range invite questions the dossier must be built to answer.<\/li>\n\n\n\n<li>Building to a limit verified in a previous year. Permitted intake limits for pregnancy and lactation have been amended, and the registration regulation itself is under revision.<\/li>\n\n\n\n<li>Using a testing facility that does not meet current eligibility conditions. The 2025 guideline is specific about which laboratories qualify, and a file from an ineligible facility is returned regardless of how the product actually performs.<\/li>\n\n\n\n<li>Treating BPOM registration and halal certification as sequential. They are separate processes with separate requirements, and running them in series extends time to market for no regulatory benefit.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Many pregnancy and breastfeeding supplement brands pursue <a href=\"https:\/\/productregistrationindonesia.com\/id\/services\/halal-certification\/\">Sertifikasi Halal<\/a> alongside BPOM registration, since halal status is a significant purchase driver in this category among Indonesian consumers and is best planned at the same stage as the supplement dossier.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Register your pregnancy or breastfeeding supplement in Indonesia<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Classification, permitted limits and claim wording are all decided before you file, and all three are cheaper to review than to correct. Book a consultation with our <a href=\"https:\/\/productregistrationindonesia.com\/id\/services\/food-supplements-registration\/\">Pendaftaran Suplemen Kesehatan<\/a> team before you finalise your formulation and label copy.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">We will confirm classification, check composition against current permitted limits, review claim wording against the applicable claims framework, and give you a case-specific timeline rather than a general estimate.<\/p>","protected":false},"excerpt":{"rendered":"<p>Most pregnancy supplement files that stall in Indonesia do not fail on safety. They fail on classification and on claim wording: two things decided long before the dossier is uploaded, and two things that are entirely within your control at the formulation stage. That is the practical shape of BPOM registration for this category. A [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":7633,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[41],"tags":[],"country":[57],"class_list":["post-7632","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-food-supplement-articles","country-indonesia"],"acf":[],"_links":{"self":[{"href":"https:\/\/productregistrationindonesia.com\/id\/wp-json\/wp\/v2\/posts\/7632","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/productregistrationindonesia.com\/id\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/productregistrationindonesia.com\/id\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/productregistrationindonesia.com\/id\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/productregistrationindonesia.com\/id\/wp-json\/wp\/v2\/comments?post=7632"}],"version-history":[{"count":1,"href":"https:\/\/productregistrationindonesia.com\/id\/wp-json\/wp\/v2\/posts\/7632\/revisions"}],"predecessor-version":[{"id":7636,"href":"https:\/\/productregistrationindonesia.com\/id\/wp-json\/wp\/v2\/posts\/7632\/revisions\/7636"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/productregistrationindonesia.com\/id\/wp-json\/wp\/v2\/media\/7633"}],"wp:attachment":[{"href":"https:\/\/productregistrationindonesia.com\/id\/wp-json\/wp\/v2\/media?parent=7632"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/productregistrationindonesia.com\/id\/wp-json\/wp\/v2\/categories?post=7632"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/productregistrationindonesia.com\/id\/wp-json\/wp\/v2\/tags?post=7632"},{"taxonomy":"country","embeddable":true,"href":"https:\/\/productregistrationindonesia.com\/id\/wp-json\/wp\/v2\/country?post=7632"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}